Clinical trial
Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung…
NCT00025571 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00025571 |
|---|---|
| Title | Photodynamic Therapy With HPPH in Treating Patients With Non-Small Cell Lung Cancer |
| Official title | A Phase I Study of Photodynamic Therapy (PDT) Using 2-(1-hexyloxyethyl)-2 Devinyl Pyropheophorbide-a (HPPH) for Treatment of Early Stage Lung Cancer - A Dose Ranging Study |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | HPPH |
| Start date | Jun 1, 2001 |
| Primary completion | Oct 1, 2002 |
| Completion | Oct 1, 2004 |
| First posted | Jun 25, 2003 |
| Last update posted | Mar 7, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: